*** This version of Confluence is for testing only and contains a copy of content from June 29th 2026. No changes will be preserved. ***
| Name | Size | Creator | Creation Date | Labels | Comment | |||
|---|---|---|---|---|---|---|---|---|
| Microsoft Powerpoint Presentation Antimicrobial Use Guidelines for Treatment of Respiratory Tract Disease in Dogs and Cats.pptx | 2.76 MB | Trevor Thomas Chan | Apr 28, 2022 14:51 |
|
||||
| Version 1 (current) | 2.76 MB | Trevor Thomas Chan | Apr 28, 2022 14:51 | |||||
| PDF File Renal electrolyte balance.pdf | 2.66 MB | user-739c2 | Jun 15, 2022 21:07 |
|
||||
| Version 2 (current) | 2.66 MB | user-739c2 | Jun 15, 2022 21:07 | |||||
| Version 1 | 2.65 MB | user-739c2 | Jun 15, 2022 21:02 | |||||
| PDF File 9781905319886.1 (1).pdf | 2.25 MB | user-a5002 | Jul 21, 2021 15:37 |
|
||||
| Version 1 (current) | 2.25 MB | user-a5002 | Jul 21, 2021 15:37 | |||||
| Microsoft Word Document ACVIM lit review Feb-June 2022.docx | 1.97 MB | user-26954 | Jul 07, 2022 14:51 |
|
||||
| Version 1 (current) | 1.97 MB | user-26954 | Jul 07, 2022 14:51 | |||||
| PDF File JSAP - abnormal platelet activity.pdf | 1.80 MB | Morgan Alexandra Stark | Nov 13, 2021 18:17 |
|
||||
| Version 1 (current) | 1.80 MB | Morgan Alexandra Stark | Nov 13, 2021 18:17 | |||||
| PDF File What I learned at IVECCS 2021 Herrera.pdf | 1.77 MB | user-ac8af | Sep 21, 2021 14:26 |
|
||||
| Version 1 (current) | 1.77 MB | user-ac8af | Sep 21, 2021 14:26 | |||||
| Microsoft Word Document Spring 2022 Lit review.docx | 1.73 MB | Unknown User (xz427) | Jun 22, 2022 21:46 |
|
||||
| Version 1 (current) | 1.73 MB | Unknown User (xz427) | Jun 22, 2022 21:46 | |||||
| Microsoft Powerpoint Presentation Portosystemic Shunts.pptx | 1.58 MB | user-ac8af | Nov 09, 2021 11:14 |
|
||||
| Version 1 (current) | 1.58 MB | user-ac8af | Nov 09, 2021 11:14 | |||||
| PDF File Nagahara_PLE_2021.pdf | 1.48 MB | Daniel J. Fletcher | Nov 03, 2021 17:06 |
|
||||
| Version 1 (current) | 1.48 MB | Daniel J. Fletcher | Nov 03, 2021 17:06 | |||||
| ZIP Archive Burns_and_immune_diseases.zip | 1.22 MB | user-ac8af | Aug 11, 2021 11:33 |
|
||||
| Version 1 (current) | 1.22 MB | user-ac8af | Aug 11, 2021 11:33 | |||||
| PDF File Veterinary Internal Medicne - 2017 - Lappin - Antimicrobial use Guidelines for Treatment of Respiratory Tract Disease in.pdf | 1.00 MB | Trevor Thomas Chan | Apr 28, 2022 14:51 |
|
||||
| Version 1 (current) | 1.00 MB | Trevor Thomas Chan | Apr 28, 2022 14:51 | |||||
| Microsoft Powerpoint Presentation GI_Hepatobiliary JVIM.pptx | 906 kB | Unknown User (emc325) | Nov 11, 2021 14:15 |
|
||||
| Version 1 (current) | 906 kB | Unknown User (emc325) | Nov 11, 2021 14:15 | |||||
| PDF File JVECC - platelet hyperactivity.pdf | 901 kB | Morgan Alexandra Stark | Nov 13, 2021 18:17 |
|
||||
| Version 1 (current) | 901 kB | Morgan Alexandra Stark | Nov 13, 2021 18:17 | |||||
| Microsoft Powerpoint Presentation Presentation1 [Autosaved].pptx | 882 kB | Unknown User (jms864) | Jul 15, 2022 03:39 |
|
||||
| Version 1 (current) | 882 kB | Unknown User (jms864) | Jul 15, 2022 03:39 | |||||
| Microsoft Powerpoint Presentation Antiplatelets and anticoagulants br.pptx | 831 kB | user-26954 | May 25, 2022 09:18 |
|
||||
| Version 2 (current) | 831 kB | user-26954 | May 25, 2022 09:18 | |||||
| Version 1 | 831 kB | user-26954 | Feb 17, 2022 14:56 | |||||
| PDF File JVECCS Aug - Nov 2021.pdf | 758 kB | user-739c2 | Nov 11, 2021 12:51 |
|
||||
| Version 1 (current) | 758 kB | user-739c2 | Nov 11, 2021 12:51 | |||||
| Microsoft Word Document Summer JVIM.docx | 662 kB | user-a5002 | Nov 11, 2021 14:35 |
|
||||
| Version 3 (current) | 662 kB | user-a5002 | Nov 11, 2021 14:35 | |||||
| Version 2 | 662 kB | user-a5002 | Nov 11, 2021 14:34 | |||||
| Version 1 | 662 kB | user-a5002 | Nov 11, 2021 14:34 | |||||
| Microsoft Powerpoint Presentation CHF.pptx | 514 kB | user-26954 | May 25, 2022 03:34 |
|
||||
| Version 1 (current) | 514 kB | user-26954 | May 25, 2022 03:34 | |||||
| PDF File Evaluation of point‐of‐care coagulation tests as alternatives to anti‐Xa activity for monitoring the anticoagulant effects of rivaroxaban in healthy dogs.pdf | 492 kB | user-ac8af | Jan 11, 2022 14:21 |
|
||||
| Version 1 (current) | 492 kB | user-ac8af | Jan 11, 2022 14:21 | |||||
| Microsoft Powerpoint Presentation CURATIVE presentation.pptx | 450 kB | Unknown User (jms864) | Jan 03, 2022 15:29 |
|
||||
| Version 1 (current) | 450 kB | Unknown User (jms864) | Jan 03, 2022 15:29 |